Intuitive Surgical (ISRG) Q4 2025: Revenue Up 18.8%, da Vinci 5 Drives Global Growth

Medical technology firm Intuitive Surgical (NASDAQ: ISRG) reported fourth-quarter revenue of $2.87 billion, an 18.8% year-over-year increase, surpassing analyst expectations. Non-GAAP earnings per share reached $2.53, exceeding consensus estimates by 11.6%. Results were fueled by higher global procedure volumes and demand for the new da Vinci 5 system, particularly in Europe and Asia. Management highlighted strong adoption across specialties and growing use in ambulatory surgery centers (ASCs). While benefiting from broader system placements and recurring revenue, the company noted challenges from tariffs and competition in China. Looking ahead, Intuitive Surgical anticipates continued growth driven by R&D investments, international expansion, and product innovation, though macroeconomic pressures and reimbursement dynamics pose risks. The stock currently trades at $528.07.